Squar Milner Financial Services’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-710
Closed -$104K 595
2020
Q1
$104K Buy
710
+109
+18% +$17.4K 0.06% 256
2019
Q4
$93K Buy
+601
New +$86.6K 0.05% 341
2019
Q3
Sell
-49
Closed -$6K 603
2019
Q2
$6K Sell
49
-47
-49% -$5.21K ﹤0.01% 580
2019
Q1
$9K Hold
96
0.01% 547
2018
Q4
$11K Hold
96
0.01% 460
2018
Q3
$11K Hold
96
0.01% 478
2018
Q2
$10K Buy
+96
New +$9.71K 0.01% 589

Other funds holding RMD

Squar Milner Financial Services's RMD Position: Q2 2020 in Review

Squar Milner Financial Services sold out of ResMed (RMD) in Q2 2020, closing a stake of 710 shares — an estimated $104K sold.

Squar Milner Financial Services first reported a position in RMD in Q2 2018 and held it in 7 quarters. The position peaked at $104K in Q1 2020. 583 funds tracked by Wall St. Rank hold RMD as of Q2 2020.

  • Squar Milner Financial Services reported no remaining ResMed position as of Q2 2020 after selling out during the quarter.
  • Squar Milner Financial Services sold 710 ResMed shares in Q2 2020, an estimated $104K.
  • Squar Milner Financial Services first reported a position in ResMed in Q2 2018 and held it in 7 quarters.
  • Squar Milner Financial Services's ResMed position peaked at $104K in Q1 2020.
  • 583 funds tracked by Wall St. Rank held ResMed as of Q2 2020.

Based on Squar Milner Financial Services's 13F filing for Q2 2020, filed 16 Jul 2020.